Rights and permissions
About this article
Cite this article
Light dims on off-label use of bevacizumab in AMD. Pharmacoecon. Outcomes News 659, 2 (2012). https://doi.org/10.2165/00151234-201206590-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206590-00004